UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Standard smoking cessation services in sites participating in the SCIMITAR+ trial for people with severe mental ill health

Heron, P; McCloud, T; Arundel, C; Bailey, D; Ker, S; Li, J; Mishu, M; ... Gilbody, S; + view all Standard smoking cessation services in sites participating in the SCIMITAR+ trial for people with severe mental ill health. BJPsych Bulletin 10.1192/bjb.2019.39. (In press). Green open access

[thumbnail of standard_smoking_cessation_services_in_sites_participating_in_the_scimitar_trial_for_people_with_severe_mental_ill_health.pdf]
Preview
Text
standard_smoking_cessation_services_in_sites_participating_in_the_scimitar_trial_for_people_with_severe_mental_ill_health.pdf - Published Version

Download (462kB) | Preview

Abstract

Aims and methodThe SCIMITAR+ trial was commissioned to evaluate the effectiveness of a bespoke smoking cessation intervention for people with severe mental ill health compared with usual services. It is difficult to define what constitutes usual care in smoking cessation services. We aimed to define what this was during the trial. Twenty-two National Health Service healthcare providers participated in a bespoke survey asking about usual care in their area. RESULTS: All sites offered smoking cessation support; however, service provider and service type varied substantially. In some cases services were not streamlined, meaning that people received smoking cessation counselling from one organisation and smoking cessation medication from another.Clinical implicationsTo better implement the National Institute for Health and Care Excellence guideline PH48, clearer referral pathways need to be implemented and communicated to patients, staff and carers. People with severe mental ill health need to be able to access services that combine nicotine replacement therapy and behavioural support in a streamlined manner.Declaration of interestNone.

Type: Article
Title: Standard smoking cessation services in sites participating in the SCIMITAR+ trial for people with severe mental ill health
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1192/bjb.2019.39
Publisher version: https://doi.org/10.1192/bjb.2019.39
Language: English
Additional information: This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike licence (http://creativecommons.org/licenses/by-nc-sa/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the same Creative Commons licence is included and the original work is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use.
Keywords: Severe mental ill health; smoking cessation; nicotine replacement therapy; schizophrenia; bipolar affective disorders.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Division of Psychiatry
URI: https://discovery.ucl.ac.uk/id/eprint/10076443
Downloads since deposit
62Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item